Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionDevelopment of pre-clinical models for evaluating the therapeutic potential of candidate siRNA targeting STAT6Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control.Using the BacMam Baculovirus System to Study Expression and Function of Recombinant Efflux Drug Transporters in Polarized Epithelial Cell MonolayersPathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesIn vitro methods to support transporter evaluation in drug discovery and development.Discovery and preclinical development of new antibiotics.Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.Transporter assays as useful in vitro tools in drug discovery and development.Interaction of S-layer proteins of Lactobacillus kefir with model membranes and cells.Predicting Transport of 3,5,6-Trichloro-2-Pyridinol Into Saliva Using a Combination Experimental and Computational Approach.Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells.Cultured enterocytes internalise bacteria across their basolateral surface for, pathogen-inhibitable, trafficking to the apical compartment.Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classificationDo Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease?The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities.Exposure Characteristics of the Analogous β-Carboline Alkaloids Harmaline and Harmine Based on the Efflux Transporter of Multidrug Resistance Protein 2.Role of ABC transporters in trans-epithelial transport of vitamin K antagonists.Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies.The permeability and transport mechanism of graphene quantum dots (GQDs) across the biological barrier.Modest Static Pressure Suppresses Columnar Epithelial Cell Growth in Association with Cell Shape and Cytoskeletal Modifications.Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice.Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process-affected water: evidence for inhibition of P-glycoprotein.In Vitro and in Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts.Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.Metabolite profiling of anhuienoside C by rat intestinal bacteria using the LC-MS metabolomic approach.Computer-aided design of amino acid-based therapeutics: a review.P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in ratsAbsorption and metabolism characteristics of rutin in Caco-2 cells
P2860
Q24273350-8182E343-1415-4B77-BD54-E5ADE33BC5EEQ28540216-27A95B94-AD90-4BB4-8BB4-887DB87E8B40Q34340279-4B1DCF98-4A21-4ACB-8A2D-9BF5E4607B9BQ36502923-CE9964DE-E3DC-4331-95BD-6CEBFA4AB779Q37264192-0345F9A1-2DBE-44FA-8969-D3DFC0AA526EQ38099194-226A2A6D-CA99-4D42-89ED-511C4C8CC798Q38197284-54EC3D8E-B0A9-4C27-AA47-9BCD1AC515BFQ38618616-F3862FB9-D982-44B6-A2A3-9C201159639BQ38619057-0B49C820-AFA7-4146-BAAE-81D0DD17C1FFQ38721683-EC9B5D76-3C2A-4D19-A99D-0ADCF5FE5B53Q38731361-307E2E81-0DAD-46E9-B140-D1190423E082Q38774819-C3DACC01-431B-4319-8893-98892AC8BCB2Q38816242-C1E919F3-7F42-446B-A9E6-403E7B53413CQ39205354-CC349625-8BB7-4588-B19B-32121FDA5EF6Q39413863-ADA6DADE-61A3-42FF-9FE0-2A59F03C1AF6Q40262879-0411CC7E-5C30-4AC0-975F-25C0AF0A26BAQ41487826-711F5B36-E76E-46DB-AC81-853F317DBC58Q42502722-B33633D8-1968-49A6-93D8-3A76B0CCDA97Q46646523-ECA9A155-1B5D-4AD1-9D8D-F7239A80A96DQ46791202-E2270EBB-C9EF-4EA9-85F0-5ACE6570F75EQ47116141-0F60B338-9CD7-4FA1-BE7E-38423158438CQ47273558-2DAF227A-8201-40B4-8F83-53C92D461940Q48323225-1A0E3F26-393F-44C8-AE2F-5AAF0B7DA082Q51367359-2CF433FF-1DB5-45C8-90A1-F9E0232A2A98Q52567148-0E4F5E11-881B-4DE4-AA26-C9C284A8404EQ52663431-CC2BA583-BC0D-4848-84CD-8AD592B37FCFQ53019981-1F6BA11B-290D-4A8C-ACFB-3754DB18FC08Q55315041-B05CCBF7-81D5-48CE-B9FC-C3BD338B027BQ57109918-8ADD222F-4B6A-4B73-A0B6-AFA7B3567E02Q59033649-EB6B5F2E-3455-4A72-AE94-BE57C9A25AA7
P2860
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@en
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@nl
type
label
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@en
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@nl
prefLabel
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@en
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@nl
P2860
P356
P1476
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
@en
P2093
Donna A Volpe
P2860
P304
P356
10.4155/FMC.11.149
P577
2011-12-01T00:00:00Z